Certara, Inc. (NASDAQ:CERT) Receives $17.08 Consensus Price Target from Brokerages

Certara, Inc. (NASDAQ:CERT) has earned a consensus rating of “Hold” from the eight analysts that are currently covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $17.08.

Several analysts recently commented on the company. Barclays reduced their target price on Certara from $16.00 to $14.00 and set an “equal weight” rating on the stock in a report on Tuesday, October 15th. Robert W. Baird dropped their target price on shares of Certara from $19.00 to $18.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. JMP Securities reaffirmed a “market perform” rating on shares of Certara in a research report on Wednesday, July 10th. KeyCorp lowered their price objective on Certara from $23.00 to $20.00 and set an “overweight” rating for the company in a research report on Thursday, July 11th. Finally, UBS Group upgraded Certara from a “neutral” rating to a “buy” rating and set a $16.00 target price on the stock in a research report on Friday, September 27th.

Insider Transactions at Certara

In related news, insider Patrick F. Smith sold 5,409 shares of the business’s stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $11.03, for a total value of $59,661.27. Following the completion of the sale, the insider now directly owns 50,091 shares of the company’s stock, valued at $552,503.73. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other Certara news, insider Leif E. Pedersen sold 51,224 shares of the firm’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $11.29, for a total value of $578,318.96. Following the transaction, the insider now directly owns 99,704 shares of the company’s stock, valued at approximately $1,125,658.16. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Patrick F. Smith sold 5,409 shares of the business’s stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $11.03, for a total transaction of $59,661.27. Following the sale, the insider now directly owns 50,091 shares of the company’s stock, valued at approximately $552,503.73. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.39% of the company’s stock.

Hedge Funds Weigh In On Certara

A number of hedge funds have recently added to or reduced their stakes in CERT. Wasatch Advisors LP lifted its holdings in shares of Certara by 23.4% in the first quarter. Wasatch Advisors LP now owns 4,924,845 shares of the company’s stock valued at $88,056,000 after purchasing an additional 932,598 shares in the last quarter. Geneva Capital Management LLC grew its holdings in shares of Certara by 15.1% in the first quarter. Geneva Capital Management LLC now owns 4,404,199 shares of the company’s stock valued at $78,747,000 after acquiring an additional 579,349 shares in the last quarter. Clearbridge Investments LLC grew its holdings in shares of Certara by 0.8% in the first quarter. Clearbridge Investments LLC now owns 4,173,195 shares of the company’s stock valued at $74,617,000 after acquiring an additional 32,846 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Certara by 9.7% during the second quarter. Dimensional Fund Advisors LP now owns 3,079,023 shares of the company’s stock valued at $42,643,000 after acquiring an additional 273,095 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its holdings in Certara by 9.8% during the second quarter. Massachusetts Financial Services Co. MA now owns 2,773,892 shares of the company’s stock worth $38,418,000 after acquiring an additional 248,448 shares during the period. Institutional investors and hedge funds own 73.96% of the company’s stock.

Certara Price Performance

Certara stock opened at $11.41 on Thursday. The company has a market capitalization of $1.84 billion, a PE ratio of -29.26, a P/E/G ratio of 5.40 and a beta of 1.49. The company has a current ratio of 2.61, a quick ratio of 2.61 and a debt-to-equity ratio of 0.28. The stock has a 50-day moving average price of $11.62 and a two-hundred day moving average price of $14.40. Certara has a 12 month low of $10.35 and a 12 month high of $19.87.

Certara (NASDAQ:CERT) last posted its earnings results on Tuesday, August 6th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.03). Certara had a positive return on equity of 3.03% and a negative net margin of 21.64%. The business had revenue of $93.31 million for the quarter, compared to analyst estimates of $96.01 million. During the same quarter in the prior year, the business earned $0.10 earnings per share. The firm’s quarterly revenue was up 3.2% on a year-over-year basis. Analysts expect that Certara will post 0.27 EPS for the current year.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.